Metsera Issues Statement in Response to Litigation Ruling
NEW YORK, Nov. 5, 2025 /PRNewswire/ — Metsera, Inc. (NASDAQ: MTSR) (“Metsera” or the “Company”) today issued the following statement in response to a ruling in the litigation filed against the Company by Pfizer: